ENLIVEN THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
ENLIVEN THERAPEUTICS, INC. (ELVN) had Lessee, Operating Lease, Liability, to be Paid, Year One of $505.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-05
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $505.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $414.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $414.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $414.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $505.00K 10-Q · filed 2026-08-05 |
| 2025-12-31 | $414.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $414.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $414.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $414.00K 10-Q · filed 2025-05-14 |
| 2023-12-31 | $341.00K 10-K · filed 2024-03-14 |
| 2023-09-30 | $341.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $341.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $341.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $329.00K 8-K · filed 2023-06-23 |
| 2022-03-31 | $622.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $278.00K 10-K · filed 2022-03-15 |
| 2021-09-30 | $278.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $278.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $278.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $273.00K 10-K · filed 2021-03-05 |
| 2020-09-30 | $273.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |